Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Event rates of patients with stable heart failure with reduced ejection fraction and newly diagnosed obstructive or central sleep apnoea.

European journal of heart failure·2026
Same author

Baroreflex activation therapy for resistant hypertension: promise present or passed?

Journal of hypertension·2026
Same author

Discordant ventilatory and efferent sympathetic responsiveness to peripheral and central chemoreflex stimulation in heart failure with reduced ejection fraction.

European journal of heart failure·2026
Same author

Reflex Neurogenic Vasoconstriction When Patients With Heart Failure Exercise: Are Females More Sympathetic Than Males?

JACC. Advances·2026
Same author

Win Ratio Analysis for Peak-Flow Adaptive Servoventilation in Treating Sleep Apnoea in Heart Failure With Reduced Ejection Fraction.

The Canadian journal of cardiology·2026
Same author

Comment on ERS/ESRS statement on adaptive servo-ventilation for treatment of central sleep apnoea.

The European respiratory journal·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jun 26, 2026

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Apnea obstructiva del sueño y sus consecuencias cardiovasculares.

T Douglas Bradley1, John S Floras

  • 1Sleep Research Laboratory of the Toronto Rehabilitation Institute, Toronto, Canada.

Lancet (London, England)
|December 23, 2008
PubMed
Resumen

La apnea obstructiva del sueño (AOS) afecta significativamente la salud cardiovascular, aumentando los riesgos de afecciones como la hipertensión y la insuficiencia cardíaca. El tratamiento de la AOS puede reducir estos riesgos, pero se necesitan grandes ensayos para confirmar la mejora de los resultados cardiovasculares.

Más Videos Relacionados

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Videos de Experimentos Relacionados

Last Updated: Jun 26, 2026

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Área de la Ciencia:

  • Cardiología Cardiología.
  • Medicina del sueño Medicina del sueño.
  • Medicina interna es la medicina interna de las enfermedades.

Sus antecedentes:

  • La apnea obstructiva del sueño (AOS) implica interrupciones respiratorias repetitivas durante el sueño.
  • Estos eventos conducen a la hipoxia, la presión intratorácica negativa y las excitaciones, estresando el sistema cardiovascular.
  • La AOS está relacionada con un mayor riesgo de hipertensión, enfermedad de las arterias coronarias, insuficiencia cardíaca y accidente cerebrovascular.

Objetivo del estudio:

  • Revisar las implicaciones cardiovasculares de la apnea obstructiva del sueño.
  • Evaluar los beneficios potenciales del tratamiento de la AOS en la salud cardiovascular.
  • Para identificar la necesidad de nuevos ensayos clínicos a gran escala.

Principales métodos:

  • Revisión de estudios epidemiológicos sobre la AOS y las enfermedades cardiovasculares.
  • Análisis de los datos de ensayos aleatorizados que investigan el tratamiento de presión positiva continua en las vías respiratorias (CPAP) para la AOS.
  • Síntesis de la evidencia actual sobre los mecanismos fisiopatológicos que vinculan la AOS a los eventos cardiovasculares.

Principales resultados:

  • La AOS desencadena estímulos cardiovasculares perjudiciales que incluyen hipoxia, activación simpática e inflamación.
  • El tratamiento con CPAP ha demostrado beneficios como la reducción de la presión arterial y la mejora de la función cardíaca en pacientes con insuficiencia cardíaca.
  • Los datos epidemiológicos asocian fuertemente la AOS con las principales enfermedades cardiovasculares.

Conclusiones:

  • La apnea obstructiva del sueño es un factor de riesgo significativo para las enfermedades cardiovasculares.
  • El tratamiento de la AOS, particularmente con CPAP, es prometedor para mitigar el riesgo cardiovascular.
  • Otros ensayos aleatorizados a gran escala son esenciales para establecer definitivamente si el tratamiento con OSA mejora los resultados cardiovasculares.